The collaboration will connect PostEra’s synthesis prediction technology with Optibrium’s comprehensive platform for design, optimisation and data analysis for small molecule discovery CAMBRIDGE, UK and BOSTON, USA – Optibrium, a leading developer of software and AI for small molecule discovery, and PostEra, an AI-first biotechnology company with advanced machine learning (ML) technology for preclinical discovery, today […]
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses PRINCETON, NJ — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, is adding deep learning capabilities to D360, a leading scientific informatics software platform. The addition of novel A.I. will enable discovery scientists to integrate multiple structured […]
Cambridge, UK – Torx® Software Limited, provider of the ground-breaking Torx technology platform for managing small molecule discovery chemistry, today Âannounced a collaboration with CAS, a division of the American Chemical Society, to connect CAS SciFindern users seamlessly through the Torx platform to streamline workflows for discovery chemistry. The integration expands on the intrinsic design and analysis capabilities within […]
New and updated fragment databases from ChEMBL and SureChEMBL are now available in Spark. This new release of databases significantly expands the available chemistry to Spark users by including the latest compounds from scientific literature, as well as previously unseen compounds from chemical patents. Combined with databases of fragments derived from screening compounds, and with custom databases which […]
New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team Latest in a series of senior hires as the Company continues its rapid growth trajectory Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of […]
-Accelerating the development of small molecule drugs using materials informatics technology- Tokyo – Hitachi High-Tech Solutions Corporation (“Hitachi High-Tech Solutions”), in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (hereinafter, “the Research”) to improve the efficiency of the development of small molecule drugs*1. Hitachi […]
The world’s most trusted source for scientific information, CAS, leverages new content, technologies, and expertise to advance its life sciences growth initiative COLUMBUS, Ohio–CAS, a division of the American Chemical Society specializing in scientific information solutions, announced several initiatives to once again transform scientific research, and empower more rapid discovery for life sciences innovation. CAS […]
New role will lead technology development as the Company continues to scale team and global business operations Appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery software Cambridge, UK and Cambridge, US – Optibrium, a leading developer of software and AI solutions for drug discovery, […]
The $1.45 million grant from National Center for Advancing Translational Sciences will allow CDD to develop an intelligent chemical structure browser Burlingame, California — Collaborative Drug Discovery has received a $1.45 million grant from National Center for Advancing Translational Sciences to develop intelligent chemical structure browser for drug discovery. Collaborative Drug Discovery, Inc. (CDD) proposes […]
Establishment of Optibrium Inc. bolsters ongoing strategic Company growth and strengthens direct US customer support Dr Tamsin Mansley promoted to President of Optibrium Inc. to lead growing US-based team and business operations CAMBRIDGE, UK and CAMBRIDGE, US – Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today announced the opening […]
Pay Invoice
Latest Blogs
-
Dividends as an Indicator for Laboratory Tool Industry Companies in 2022
February 1, 2023 9:00 am
-
Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
January 5, 2023 9:13 pm
-
Danaher Investor Day 2022 Showcases Big Announcements and Focuses on Cytiva
September 27, 2022 5:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
